Beckman Coulter's Q2 Revenues Rise 12 Percent, Profit Swells 56 Percent | GenomeWeb
NEW YORK (GenomeWeb News) - Beckman Coulter today said second-quarter revenues increased 12 percent as R&D spending was down 22 percent and profit grew 56 percent.
Total receipts for the three months ended June 30 increased to $689.7 million from $616.3 million year over year.
Product-related revenue increased 13 percent to $584.7 million while service-related revenue was up 7 percent to $105 million. Sales of consumables grew 10.3 percent, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.